Literature DB >> 24685692

The Clouston syndrome mutation connexin30 A88V leads to hyperproliferation of sebaceous glands and hearing impairments in mice.

Felicitas Bosen1, Melanie Schütz1, Anna Beinhauer1, Nicola Strenzke2, Thomas Franz3, Klaus Willecke4.   

Abstract

Distinct mutations in the gap junction protein connexin30 (Cx30) can cause the ectodermal dysplasia Clouston syndrome in humans. We have generated a new mouse line expressing the Clouston syndrome mutation Cx30A88V under the control of the endogenous Cx30 promoter. Our results show that the mutated Cx30A88V protein is incorporated in gap junctional plaques of the epidermis. Homozygous Cx30A88V mice reveal hyperproliferative and enlarged sebaceous glands as well as a mild palmoplantar hyperkeratosis. Additionally, homozygous mutant mice show an altered hearing profile compared to control mice. We conclude that the Cx30A88V mutation triggers hyperproliferation in the skin and changes the cochlear homeostasis in mice.
Copyright © 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clouston syndrome; Connexin30; Gap junction; Point mutation; Transgenic mouse line

Mesh:

Substances:

Year:  2014        PMID: 24685692     DOI: 10.1016/j.febslet.2014.03.040

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  A potent antagonist antibody targeting connexin hemichannels alleviates Clouston syndrome symptoms in mutant mice.

Authors:  Yuanyuan Kuang; Veronica Zorzi; Damiano Buratto; Gaia Ziraldo; Flavia Mazzarda; Chiara Peres; Chiara Nardin; Anna Maria Salvatore; Francesco Chiani; Ferdinando Scavizzi; Marcello Raspa; Min Qiang; Youjun Chu; Xiaojie Shi; Yu Li; Lili Liu; Yaru Shi; Francesco Zonta; Guang Yang; Richard A Lerner; Fabio Mammano
Journal:  EBioMedicine       Date:  2020-06-15       Impact factor: 8.143

Review 2.  Connexins and pannexins in the integumentary system: the skin and appendages.

Authors:  Chrysovalantou Faniku; Catherine S Wright; Patricia E Martin
Journal:  Cell Mol Life Sci       Date:  2015-06-20       Impact factor: 9.261

Review 3.  Therapeutic strategies targeting connexins.

Authors:  Dale W Laird; Paul D Lampe
Journal:  Nat Rev Drug Discov       Date:  2018-10-12       Impact factor: 84.694

4.  Commercially derived versatile optical architecture for two-photon STED, wavelength mixing and label-free microscopy.

Authors:  Chiara Peres; Chiara Nardin; Guang Yang; Fabio Mammano
Journal:  Biomed Opt Express       Date:  2022-02-14       Impact factor: 3.732

5.  Connexin hemichannels influence genetically determined inflammatory and hyperproliferative skin diseases.

Authors:  Noah A Levit; Thomas W White
Journal:  Pharmacol Res       Date:  2015-07-23       Impact factor: 7.658

Review 6.  Inner Ear Connexin Channels: Roles in Development and Maintenance of Cochlear Function.

Authors:  Fabio Mammano
Journal:  Cold Spring Harb Perspect Med       Date:  2019-07-01       Impact factor: 6.915

7.  Connexin26 hemichannels with a mutation that causes KID syndrome in humans lack sensitivity to CO2.

Authors:  Louise Meigh; Naveed Hussain; Daniel K Mulkey; Nicholas Dale
Journal:  Elife       Date:  2014-11-25       Impact factor: 8.140

8.  Design and Characterization of a Human Monoclonal Antibody that Modulates Mutant Connexin 26 Hemichannels Implicated in Deafness and Skin Disorders.

Authors:  Liang Xu; Andrea Carrer; Francesco Zonta; Zhihu Qu; Peixiang Ma; Sheng Li; Federico Ceriani; Damiano Buratto; Giulia Crispino; Veronica Zorzi; Gaia Ziraldo; Francesca Bruno; Chiara Nardin; Chiara Peres; Flavia Mazzarda; Anna M Salvatore; Marcello Raspa; Ferdinando Scavizzi; Youjun Chu; Sichun Xie; Xuemei Yang; Jun Liao; Xiao Liu; Wei Wang; Shanshan Wang; Guang Yang; Richard A Lerner; Fabio Mammano
Journal:  Front Mol Neurosci       Date:  2017-09-22       Impact factor: 5.639

9.  A connexin30 mutation rescues hearing and reveals roles for gap junctions in cochlear amplification and micromechanics.

Authors:  Victoria A Lukashkina; Snezana Levic; Andrei N Lukashkin; Nicola Strenzke; Ian J Russell
Journal:  Nat Commun       Date:  2017-02-21       Impact factor: 14.919

10.  Connexin hemichannel inhibition improves skin pathology in Clouston syndrome mice.

Authors:  Roberto Bruzzone; Thomas W White
Journal:  EBioMedicine       Date:  2020-07-03       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.